Comparison Overview
Johnson & Johnson Innovative Medicine

Johnson & Johnson Innovative Medicine
N/A
Last Update: 18/09/2026
At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with co...

Lonza
Muenchensteinerstr. 38, Basel, CH, 4002
Last Update: 13/09/2026
Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicine...
Compliance Ranges Comparison

Johnson & Johnson Innovative Medicine







Lonza






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Johnson & Johnson Innovative Medicine in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Lonza in 2026.
Incident History - Johnson & Johnson Innovative Medicine (X = Date, Y = Severity)
Johnson & Johnson Innovative Medicine cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Lonza (X = Date, Y = Severity)
Lonza cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Johnson & Johnson Innovative Medicine

Lonza
FAQ
Latest Global CVEs
IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to exposure of session tokens in the HTML response.
IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to an XML external entity (XXE) injection flaw.
IBM Aspera Enterprise WebApps 1.0.0 through 1.0.6 could allow a local attacker to obtain sensitive information due to cleartext transmission of sensitive information.
IBM Planning Analytics 2.0, and 2.1 could allow a remote authenticated attacker to execute arbitrary code due to a stack-based buffer overflow.
IBM DataStage on Cloud Pak for Data 5.4.0.0 can allow a man-in-the-middle attacker to present a forged TLS certificate, intercept the connection, and capture the IAM bearer Authorization header automatically attached by the session adapter. The captured token grants full platform-scope tenant API access, enabling the attacker to read and manipulate the victim's DataStage projects, flows, assets, and pipeline definitions. This is client-side SDK code running on the user's own machine, so exploitation requires an external network interceptor rather than a co-tenant in the shared cluster.